Name: Global Oral Anti-Diabetic Drug Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.8 (199 reviews)

Global Oral Anti-Diabetic Drug Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Extent Research has published a report on Global Oral Anti-Diabetic Drug Market in order to provide the crucial market details including market stability, growth rate, and financial fluctuations. The economic gains and losses are well portrayed in the report in the tabular, bar diagram, and other representative formats to offer a better understanding of the market future and position on both the domestic and global platform. The report also covers the market latest developments, opportunities & challenges, threats, and various strategic moves adopted by the participants operating in the Global Oral Anti-Diabetic Drug Market. Our analysts have used primary or secondary research and research methodologies including SWOT Analysis, PESTEL Analysis, and Porter’s 5 Force to offer market facts such as industrial analysis, competitive study, historical or future trends, external or internal stress, statistical growth, and drivers.

Data provided by Extent Research. Source: https://www.extentresearch.com/oral-anti-diabetic-drug-market

Market Players:

Some of the key players operating in the Global Oral Anti-Diabetic Drug Market include Takeda, Pfizer, Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck And Co., AstraZeneca, Bristol Myers Squibb, Novartis, Sanofi, Abbott, Biocon, . These players adopt various intelligent methods including acquisition, mergers, joint ventures, agreements, new product launches, advancements in the manufacturing process, and other business strategies to sustain in this competitive market. The report comprehensively explains the competitive landscape in terms of both financial and market viability to poster better knowledge about the Oral Anti-Diabetic Drug Market through the company profiling of numerous key players. Over the forecast, the various trends and market approaches used by the players operating in the Global Oral Anti-Diabetic Drug Market to combat the pre- and post-COVID impact are also well postulated in this report.

Geographical Distribution:

In addition to the competitive landscape, the report enlightens the readers and customers with geographical distribution that primarily explains the regional market attractiveness, supply & demand ratio, distribution channels, consumer preference, changing consumer behavior, and regional market boons and banes through theoretical and figurative forms. The regions favorable for the Global Oral Anti-Diabetic Drug Market include North America, Europe, Asia Pacific, Latin America, Middle East & Africa. The regional analysis provides a complete breakdown structure of the market through the numerical gains or losses along with the product sales model in particular regions.

It is thus clear that our report is immaculate enough to provide all the market information necessary to understand the market status, growth rate, drivers, opportunities & restraints, and future scope over the forecast period.

Segmentation of the Global Oral Anti-Diabetic Drug Market:

By Product type

Glimepiride, Gliclazide, Glyburide, Others,

by Application

Hospital, Research Institual,

Report Scope and Market Segmentation

ATTRIBUTES	Global Oral Anti-Diabetic Drug Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Oral Anti-Diabetic Drug Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Oral Anti-Diabetic Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Oral Anti-Diabetic Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Glimepiride
        1.2.3 Gliclazide
        1.2.4 Glyburide
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Oral Anti-Diabetic Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospital
        1.3.3 Research Institual
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Oral Anti-Diabetic Drug Sales Estimates and Forecasts 2017-2035
    2.2 Global Oral Anti-Diabetic Drug Revenue Estimates and Forecasts 2017-2035
    2.3 Global Oral Anti-Diabetic Drug Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Oral Anti-Diabetic Drug Sales by Region
        2.4.1 Global Oral Anti-Diabetic Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Oral Anti-Diabetic Drug by Region (2023-2035)
    2.5 Global Oral Anti-Diabetic Drug Revenue by Region
        2.5.1 Global Oral Anti-Diabetic Drug Revenue by Region (2017-2022)
        2.5.2 Global Oral Anti-Diabetic Drug Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Oral Anti-Diabetic Drug Sales by Manufacturers
        3.1.1 Global Top Oral Anti-Diabetic Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Anti-Diabetic Drug in 2021
    3.2 Global Oral Anti-Diabetic Drug Revenue by Manufacturers
        3.2.1 Global Oral Anti-Diabetic Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Oral Anti-Diabetic Drug Revenue in 2021
    3.3 Global Oral Anti-Diabetic Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Oral Anti-Diabetic Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Oral Anti-Diabetic Drug Sales by Type
        4.1.1 Global Oral Anti-Diabetic Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Oral Anti-Diabetic Drug Forecasted Sales by Type (2023-2035)
        4.1.3 Global Oral Anti-Diabetic Drug Sales Market Share by Type (2017-2035)
    4.2 Global Oral Anti-Diabetic Drug Revenue by Type
        4.2.1 Global Oral Anti-Diabetic Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Oral Anti-Diabetic Drug Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2017-2035)
    4.3 Global Oral Anti-Diabetic Drug Price by Type
        4.3.1 Global Oral Anti-Diabetic Drug Price by Type (2017-2022)
        4.3.2 Global Oral Anti-Diabetic Drug Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Oral Anti-Diabetic Drug Sales by Application
        5.1.1 Global Oral Anti-Diabetic Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Oral Anti-Diabetic Drug Forecasted Sales by Application (2023-2035)
        5.1.3 Global Oral Anti-Diabetic Drug Sales Market Share by Application (2017-2035)
    5.2 Global Oral Anti-Diabetic Drug Revenue by Application
        5.2.1 Global Oral Anti-Diabetic Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Oral Anti-Diabetic Drug Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2017-2035)
    5.3 Global Oral Anti-Diabetic Drug Price by Application
        5.3.1 Global Oral Anti-Diabetic Drug Price by Application (2017-2022)
        5.3.2 Global Oral Anti-Diabetic Drug Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Oral Anti-Diabetic Drug Market Size by Type
        6.1.1 North America Oral Anti-Diabetic Drug Sales by Type (2017-2035)
        6.1.2 North America Oral Anti-Diabetic Drug Revenue by Type (2017-2035)
    6.2 North America Oral Anti-Diabetic Drug Market Size by Application
        6.2.1 North America Oral Anti-Diabetic Drug Sales by Application (2017-2035)
        6.2.2 North America Oral Anti-Diabetic Drug Revenue by Application (2017-2035)
    6.3 North America Oral Anti-Diabetic Drug Market Size by Country
        6.3.1 North America Oral Anti-Diabetic Drug Sales by Country (2017-2035)
        6.3.2 North America Oral Anti-Diabetic Drug Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Oral Anti-Diabetic Drug Market Size by Type
        7.1.1 Europe Oral Anti-Diabetic Drug Sales by Type (2017-2035)
        7.1.2 Europe Oral Anti-Diabetic Drug Revenue by Type (2017-2035)
    7.2 Europe Oral Anti-Diabetic Drug Market Size by Application
        7.2.1 Europe Oral Anti-Diabetic Drug Sales by Application (2017-2035)
        7.2.2 Europe Oral Anti-Diabetic Drug Revenue by Application (2017-2035)
    7.3 Europe Oral Anti-Diabetic Drug Market Size by Country
        7.3.1 Europe Oral Anti-Diabetic Drug Sales by Country (2017-2035)
        7.3.2 Europe Oral Anti-Diabetic Drug Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Oral Anti-Diabetic Drug Market Size by Type
        8.1.1 Asia Pacific Oral Anti-Diabetic Drug Sales by Type (2017-2035)
        8.1.2 Asia Pacific Oral Anti-Diabetic Drug Revenue by Type (2017-2035)
    8.2 Asia Pacific Oral Anti-Diabetic Drug Market Size by Application
        8.2.1 Asia Pacific Oral Anti-Diabetic Drug Sales by Application (2017-2035)
        8.2.2 Asia Pacific Oral Anti-Diabetic Drug Revenue by Application (2017-2035)
    8.3 Asia Pacific Oral Anti-Diabetic Drug Market Size by Region
        8.3.1 Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2017-2035)
        8.3.2 Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Oral Anti-Diabetic Drug Market Size by Type
        9.1.1 Latin America Oral Anti-Diabetic Drug Sales by Type (2017-2035)
        9.1.2 Latin America Oral Anti-Diabetic Drug Revenue by Type (2017-2035)
    9.2 Latin America Oral Anti-Diabetic Drug Market Size by Application
        9.2.1 Latin America Oral Anti-Diabetic Drug Sales by Application (2017-2035)
        9.2.2 Latin America Oral Anti-Diabetic Drug Revenue by Application (2017-2035)
    9.3 Latin America Oral Anti-Diabetic Drug Market Size by Country
        9.3.1 Latin America Oral Anti-Diabetic Drug Sales by Country (2017-2035)
        9.3.2 Latin America Oral Anti-Diabetic Drug Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Oral Anti-Diabetic Drug Market Size by Type
        10.1.1 Middle East and Africa Oral Anti-Diabetic Drug Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Type (2017-2035)
    10.2 Middle East and Africa Oral Anti-Diabetic Drug Market Size by Application
        10.2.1 Middle East and Africa Oral Anti-Diabetic Drug Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Application (2017-2035)
    10.3 Middle East and Africa Oral Anti-Diabetic Drug Market Size by Country
        10.3.1 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Takeda
        11.1.1 Takeda Corporation Information
        11.1.2 Takeda Overview
        11.1.3 Takeda Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Takeda Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Takeda Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 Eli Lilly
        11.3.1 Eli Lilly Corporation Information
        11.3.2 Eli Lilly Overview
        11.3.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Eli Lilly Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Eli Lilly Recent Developments
    11.4 Janssen Pharmaceuticals
        11.4.1 Janssen Pharmaceuticals Corporation Information
        11.4.2 Janssen Pharmaceuticals Overview
        11.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Janssen Pharmaceuticals Recent Developments
    11.5 Astellas
        11.5.1 Astellas Corporation Information
        11.5.2 Astellas Overview
        11.5.3 Astellas Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Astellas Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Astellas Recent Developments
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Corporation Information
        11.6.2 Boehringer Ingelheim Overview
        11.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Boehringer Ingelheim Recent Developments
    11.7 Merck And Co.
        11.7.1 Merck And Co. Corporation Information
        11.7.2 Merck And Co. Overview
        11.7.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Merck And Co. Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Merck And Co. Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Corporation Information
        11.8.2 AstraZeneca Overview
        11.8.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 AstraZeneca Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 AstraZeneca Recent Developments
    11.9 Bristol Myers Squibb
        11.9.1 Bristol Myers Squibb Corporation Information
        11.9.2 Bristol Myers Squibb Overview
        11.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bristol Myers Squibb Recent Developments
    11.10 Novartis
        11.10.1 Novartis Corporation Information
        11.10.2 Novartis Overview
        11.10.3 Novartis Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novartis Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novartis Recent Developments
    11.11 Sanofi
        11.11.1 Sanofi Corporation Information
        11.11.2 Sanofi Overview
        11.11.3 Sanofi Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Sanofi Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Sanofi Recent Developments
    11.12 Abbott
        11.12.1 Abbott Corporation Information
        11.12.2 Abbott Overview
        11.12.3 Abbott Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Abbott Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Abbott Recent Developments
    11.13 Biocon
        11.13.1 Biocon Corporation Information
        11.13.2 Biocon Overview
        11.13.3 Biocon Oral Anti-Diabetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Biocon Oral Anti-Diabetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Biocon Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Oral Anti-Diabetic Drug Industry Chain Analysis
    12.2 Oral Anti-Diabetic Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oral Anti-Diabetic Drug Production Mode & Process
    12.4 Oral Anti-Diabetic Drug Sales and Marketing
        12.4.1 Oral Anti-Diabetic Drug Sales Channels
        12.4.2 Oral Anti-Diabetic Drug Distributors
    12.5 Oral Anti-Diabetic Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Oral Anti-Diabetic Drug Industry Trends
    13.2 Oral Anti-Diabetic Drug Market Drivers
    13.3 Oral Anti-Diabetic Drug Market Challenges
    13.4 Oral Anti-Diabetic Drug Market Restraints
14 Key Findings in The Global Oral Anti-Diabetic Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Oral Anti-Diabetic Drug Market